Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
NasdaqGS - Nasdaq Real Time Price USD

Sabra Health Care REIT, Inc. (SBRA)

Compare
16.86
+0.29
+(1.75%)
At close: March 7 at 4:00:01 PM EST
17.09
+0.23
+(1.36%)
After hours: March 7 at 7:36:02 PM EST
Loading Chart for SBRA
  • Previous Close 16.57
  • Open 16.58
  • Bid 12.22 x 200
  • Ask 21.33 x 200
  • Day's Range 16.49 - 17.00
  • 52 Week Range 13.31 - 20.03
  • Volume 2,255,641
  • Avg. Volume 2,151,570
  • Market Cap (intraday) 4.011B
  • Beta (5Y Monthly) 1.25
  • PE Ratio (TTM) 31.22
  • EPS (TTM) 0.54
  • Earnings Date May 6, 2025 - May 12, 2025
  • Forward Dividend & Yield 1.20 (7.12%)
  • Ex-Dividend Date Feb 14, 2025
  • 1y Target Est 19.58

As of September 30, 2024, Sabra's investment portfolio included 373 real estate properties held for investment (consisting of (i) 233 skilled nursing/transitional care facilities, (ii) 39 senior housing communities (“senior housing - leased”), (iii) 68 senior housing communities operated by third-party property managers pursuant to property management agreements (“senior housing - managed”), (iv) 18 behavioral health facilities and (v) 15 specialty hospitals and other facilities), 14 investments in loans receivable (consisting of three mortgage loans and 11 other loans), five preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2024, Sabra's real estate properties held for investment included 37,793 beds/units, spread across the United States and Canada.

www.sabrahealth.com

50

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SBRA

View More

Performance Overview: SBRA

Trailing total returns as of 3/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 .

YTD Return

SBRA
0.87%
S&P 500
1.89%

1-Year Return

SBRA
32.76%
S&P 500
11.88%

3-Year Return

SBRA
66.16%
S&P 500
37.35%

5-Year Return

SBRA
36.59%
S&P 500
94.13%

Compare To: SBRA

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SBRA

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    4.01B

  • Enterprise Value

    6.40B

  • Trailing P/E

    31.22

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    5.66

  • Price/Book (mrq)

    1.46

  • Enterprise Value/Revenue

    9.09

  • Enterprise Value/EBITDA

    15.50

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    18.03%

  • Return on Assets (ttm)

    3.00%

  • Return on Equity (ttm)

    4.57%

  • Revenue (ttm)

    702.64M

  • Net Income Avi to Common (ttm)

    126.71M

  • Diluted EPS (ttm)

    0.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    81.94M

  • Total Debt/Equity (mrq)

    88.50%

  • Levered Free Cash Flow (ttm)

    250.41M

Research Analysis: SBRA

View More

Company Insights: SBRA

Research Reports: SBRA

View More

People Also Watch